InMed Pharmaceuticals (INM) Q1 2026 Earnings

6MayConfirmed
Q2 2025
Q4 2025
Q1 2026
Q1 2026
-1.94
-1.52
-1.11
-0.69

Details

Expected EPS
N/A
Actual EPS
-0.69
Surprise EPS
-0.69
Surprise Percent
+∞%

Description

InMed Pharmaceuticals (INM) has reported earnings of -0.69 per share for Q1 2026.

0 Comments

Share your thoughts